THALITONE Drug Patent Profile

✉ Email this page to a colleague

When do Thalitone patents expire, and what generic alternatives are available?

Thalitone is a drug marketed by Casper Pharma Llc and Monarch Pharms and is included in two NDAs.

The generic ingredient in THALITONE is chlorthalidone. There are twenty-one drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the chlorthalidone profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Thalitone

A generic version of THALITONE was approved as chlorthalidone by SUN PHARM INDUSTRIES on July 21^st, 1986.

Try a Trial

Summary for THALITONE

US Patents:	0
Applicants:	2
NDAs:	2
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	105
Clinical Trials:	4
Patent Applications:	4,046
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for THALITONE
What excipients (inactive ingredients) are in THALITONE?	THALITONE excipients list
DailyMed Link:	THALITONE at DailyMed

Drug patent expirations by year for THALITONE

Recent Clinical Trials for THALITONE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Anthony J Viera, MD, MPH	N/A
North Carolina Translational and Clinical Sciences Institute	N/A
Virginia Commonwealth University	Phase 4

See all THALITONE clinical trials

Pharmacology for THALITONE

Drug Class	Thiazide-like Diuretic
Physiological Effect	Increased Diuresis

US Patents and Regulatory Information for THALITONE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Casper Pharma Llc	THALITONE	chlorthalidone	TABLET;ORAL	019574-001	Dec 20, 1988		RX	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Casper Pharma Llc	THALITONE	chlorthalidone	TABLET;ORAL	019574-002	Feb 12, 1992	BX	RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Monarch Pharms	THALITONE	chlorthalidone	TABLET;ORAL	088051-001	Nov 12, 1982		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for THALITONE

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Casper Pharma Llc	THALITONE	chlorthalidone	TABLET;ORAL	019574-001	Dec 20, 1988	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for THALITONE

See the table below for patents covering THALITONE around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Mexico	9203256	COMPOSICION FARMACEUTICA DE CLORTALIDONA, EN FORMA DE TABLETA, SOLUBLE EN AGUA.	⤷ Try a Trial
Croatia	P940726	PROCESS FOR THE PREPARATION OF WATERSOLUBLE PHARMACEUTICALLY ACCEPTABLE DISPERSION OF CHLORTHALIDONE IN A SOLID STATE	⤷ Try a Trial
Portugal	78259	NOVEL PROCESS AND PRODUCT	⤷ Try a Trial
Norway	841010		⤷ Try a Trial
Spain	530628		⤷ Try a Trial
Japan	S59176212	AQUEOUS SOLUTION DISPERSION OF CHLOROSALIDONE	⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for THALITONE

Recent Clinical Trials for THALITONE

Pharmacology for THALITONE

Make Better Decisions: Try a trial or see plans & pricing